P-279: Pembrolizumab for patients with previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: phase 2 KEYNOTE-180 study
P-279:帕博利珠单抗治疗既往接受过治疗的转移性食管腺癌或鳞状细胞癌患者:KEYNOTE-180 II期研究
期刊:Genome Medicine
影响因子:11.2
doi:10.1186/s13073-019-0625-y
Galipeau, Patricia C; Oman, Kenji M; Paulson, Thomas G; Sanchez, Carissa A; Zhang, Qing; Marty, Jerry A; Delrow, Jeffrey J; Kuhner, Mary K; Vaughan, Thomas L; Reid, Brian J; Li, Xiaohong; Manish, Shah; Jaafar, Bennouna; Lin, Shen; Peter, Enzinger; Qiao, Li; Ildiko, Csiki; Minori, Koshiji; Toshihiko, Doi